Page last updated: 2024-10-23

benzyl isothiocyanate and Non-alcoholic Fatty Liver Disease

benzyl isothiocyanate has been researched along with Non-alcoholic Fatty Liver Disease in 2 studies

benzyl isothiocyanate: inhibits carcinogen-induced neoplasia; structure in Negwer, 5th ed, #715; also promotes urinary bladder carcinoma

Non-alcoholic Fatty Liver Disease: Fatty liver finding without excessive ALCOHOL CONSUMPTION.

Research Excerpts

ExcerptRelevanceReference
"Incidence of nonalcoholic fatty liver disease is increasing worldwide."1.56Benzyl isothiocyanate ameliorates high-fat/cholesterol/cholic acid diet-induced nonalcoholic steatohepatitis through inhibiting cholesterol crystal-activated NLRP3 inflammasome in Kupffer cells. ( Chen, CC; Chen, HW; Huang, CS; Kuo, LL; Lii, CK; Lo, CW; Yen, CC, 2020)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Lo, CW2
Yen, CC2
Chen, CY1
Chen, HW2
Lii, CK2
Kuo, LL1
Huang, CS1
Chen, CC1

Other Studies

2 other studies available for benzyl isothiocyanate and Non-alcoholic Fatty Liver Disease

ArticleYear
Benzyl isothiocyanate attenuates activation of the NLRP3 inflammasome in Kupffer cells and improves diet-induced steatohepatitis.
    Toxicology and applied pharmacology, 2023, 03-01, Volume: 462

    Topics: Animals; Cholesterol; Diet, High-Fat; Inflammasomes; Inflammation; Insulin Resistance; Interleukin-1

2023
Benzyl isothiocyanate ameliorates high-fat/cholesterol/cholic acid diet-induced nonalcoholic steatohepatitis through inhibiting cholesterol crystal-activated NLRP3 inflammasome in Kupffer cells.
    Toxicology and applied pharmacology, 2020, 04-15, Volume: 393

    Topics: Animals; Cholesterol; Cholesterol, Dietary; Cholic Acid; Diet, High-Fat; Dose-Response Relationship,

2020